Kelly is Co-Founder and CEO of Fisher Wallace Labs, a neurotechnology company developing wearable brain stimulation to restore, preserve and optimize brain function for mental health and human performance. The company's technology is scientifically validated to treat depression, anxiety, insomnia, with additional real world data on restoring autonomic function and increasing cognitive resilience. Version 2.0 is currently being pilot tested by the U.S. Department of Veterans Affairs and is on track for regulatory approval in 2026.
Kelly Roman has been a guest on 1 episode.
-
One Device for Depression, Anxiety & Insomnia: Fisher Wallace Labs
June 8th, 2026 | Season 3 | 41 mins 28 secs
Kelly Roman went from a Harvard English degree and a graphic-novel adaptation of "The Art of War" to running one of the only brain-stimulation companies on a path to FDA approval. He joins Grant Chapman and Drew Westrick to unpack Fisher Wallace's nearly 17-year journey: designing a sham device you genuinely can't feel, why depression is regulated as a Class III device, and the brutal economics of clinical trials, reimbursement, and IP in prescription hardware.